Aprotinin is a potent multi-target drug for the combination therapy of moderate COVID-19 cases respiratory syndrome coronavirus 2 (SARS-Co
V-2). We have studied the efficacy of Aprotinin (nonspecific serine
Collective immunity to SARS-COV-2 of moscow residents during the COVID-19 epidemic period and structure of population immunity to the SARS-Co
V-2 virus among the population of Moscow against